Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 15,881Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Emend

02 4Emend/Proemend

PharmaCompass

01

Brand Name : Emend/Proemend

Aprepitant

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Emend/Proemend

arrow
Fi Europe 2024
Not Confirmed

Aprepitant

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 55

2019 Revenue in Millions : 107

Growth (%) : -49

blank

02

Brand Name : Emend

Aprepitant

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Emend

arrow
Fi Europe 2024
Not Confirmed

Aprepitant

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 145

2019 Revenue in Millions : 388

Growth (%) : -63

blank

03

Brand Name : Emend

Aprepitant

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Emend

arrow
Fi Europe 2024
Not Confirmed

Aprepitant

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 127

2020 Revenue in Millions : 145

Growth (%) : -12

blank

04

Brand Name : Emend

Aprepitant

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Emend

arrow
Fi Europe 2024
Not Confirmed

Aprepitant

Main Therapeutic Indication : Others

Currency : USD

2015 Revenue in Millions : 553

2014 Revenue in Millions : 535

Growth (%) : -3%

blank

05

Brand Name : Emend

Aprepitant

arrow
Fi Europe 2024
Not Confirmed

06

Brand Name : Emend

Aprepitant

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Emend

arrow
Fi Europe 2024
Not Confirmed

Aprepitant

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 549

2015 Revenue in Millions : 535

Growth (%) : 3

blank

07

Brand Name : Emend

Aprepitant

arrow
Fi Europe 2024
Not Confirmed

08

Brand Name : Emend

Aprepitant

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Emend

arrow
Fi Europe 2024
Not Confirmed

Aprepitant

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 522

2017 Revenue in Millions : 556

Growth (%) : -6%

blank

09

Brand Name : Emend/Proemend

Aprepitant

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Emend/Proemend

arrow
Fi Europe 2024
Not Confirmed

Aprepitant

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 97

2016 Revenue in Millions : 94

Growth (%) : 3

blank

10

Brand Name : Emend

Aprepitant

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Emend

arrow
Fi Europe 2024
Not Confirmed

Aprepitant

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 388

2018 Revenue in Millions : 522

Growth (%) : -26

blank